Estrogen receptor modulators and uses thereof
US-9873684-B2 · Jan 23, 2018 · US
Hepatitis B core protein modulators
US10377748B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10377748-B2 |
| Application number | US-201615760284-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 15, 2016 |
| Priority date | Sep 15, 2015 |
| Publication date | Aug 13, 2019 |
| Grant date | Aug 13, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound having the following formula: or a pharmaceutically acceptable salt thereof. 2. A pharmaceutically acceptable composition comprising the compound of claim 1 , and a pharmaceutically acceptable excipient. 3. A method of treating a hepatitis B infection in a patient in need thereof, comprising administering to said patient an effective amount of the compound of claim 1 , or a pharmaceutically acceptable salt thereof.
Assignees
Inventors
Classifications
- C07D417/12Primary
linked by a chain containing hetero atoms as chain links · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
- C07D281/16Primary
[b, f]-condensed · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10377748B2 cover?
- The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.
- Who is the assignee on this patent?
- Assembly Biosciences Inc, Univ Indiana Res & Tech Corp
- What technology area does this patent fall under?
- Primary CPC classification C07D417/12. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).